Price $150.27 |
Market Cap
378.24B
|
Sector Health Care |
Div. Growth
5.90%
|
|
P/E
23.0
|
P/B
5.88
|
P/S
4.69
|
Dividend %
2.80%
|
|
P/CF
141.9
|
P/FCF
48.2
|
Op. Cash Flow
21.59M
|
FCF
2.9
|
|
Op. Margin
23.60%
|
Net Margin
21.00%
|
ROE
27.40%
|
ROI
17.30%
|
|
ROA
10.60%
|
EPS Growth
21.20%
|
Current Ratio
1.3
|
Debt/Equity
44.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings Inc (ZBH) | $149.05 | - | 0.60% | 31.03B | Strong Buy |
| IRIDEX Corporation (IRIX) | $1.92 | - | - | 23.6M | Strong Buy |
| Boston Scientific Corporation (BSX) | $34.41 | - | - | 48.04B | Strong Buy |
| Elite Pharmaceuticals Inc (ELTP) | $0.05 | - | - | 55.5M | Strong Buy |
| Assembly Biosciences Inc (ASMB) | $6.21 | - | - | 188.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
